| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.03 | 0.8 |